Eli Lilly and Company
Eli Lilly is a healthcare and pharmaceutical company and is USA based MNC company. Key business areas are Oncology, Bio-Medicines, Diabetes and also Animals Health. Headquarters is in USA.
As of Jan-05-2024, Eli Lilly market cap was 586 Billion USD and it is World Top 10th rank company by market cap.
As of August 2, 2026, Eli Lilly and Company had a market capitalization of approximately 1,029 billion USD, making it the world’s 14th-largest company by market capitalization.
Eli Lilly Annual Revenue for the year ending December 2025 was 65,179 million USD, and Annual Net Income was 20,640 million USD.
Eli Lilly Annual Revenue for the year ending December 2024 was 45,043 million USD, and Annual Net Income was 10,590 million USD.
Eli Lilly Annual Revenue for the year ending December 2023 was 34,124 million USD, and Annual Net Income was 5,240 million USD.
As of December 31, 2025, Eli Lilly had approximately 50,000 employees worldwide.
As of December 31, 2024, Eli Lilly had approximately 47,000 employees worldwide.